After an allogeneic stem cell transplant, a recipient’s body faces a daunting task: rebuilding the person’s blood-forming and ...

It's not fully appreciated how much of an impact sickle cell disease can have on a person's mental health, writes columnist.

Columnist Oluwatosin Adesoye shares a list of things that everyone should know and understand about sickle cell disease.

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

Vertex aims to further bolster its gene-editing therapy pipeline by using Orna's lipid nanoparticle delivery technologies during the three-year collaboration.

Vertex is paying Orna $65 million upfront, in part via convertible note, according to a Jan. 7 release. Orna—which acquired ...

CTX-131 is under clinical development by CRISPR Therapeutics and currently in Phase II for Mantle Cell Lymphoma.